AAAAAA
Results:
1-10
|
Results: 10
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Arnaouti, T
Kalahanis, N
Tsigris, C
Giannopoulos, A
Karatzas, G
Giannikos, L
Sfikakis, PP
Citation: A. Polyzos et al., Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience, ONCOL-BASEL, 61(2), 2001, pp. 129-133
Authors:
Kosmas, C
Tsavaris, N
Vadiaka, M
Stavroyianni, N
Koutras, A
Malamos, N
Onyenadum, A
Rokana, S
Polyzos, A
Kalofonos, HP
Citation: C. Kosmas et al., Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens, CANCER, 92(11), 2001, pp. 2902-2910
Authors:
Polyzos, A
Kosmas, C
Tsavaris, N
Markopoulos, C
Kalahanis, N
Papadopoulos, O
Arnaouti, T
Sfikakis, PP
Citation: A. Polyzos et al., Doxorubicin plus ifosfamide as salvage treatment for patients with advanced breast cancer refractory to epirubicin plus cyclophosphamide, CLIN DRUG I, 19(5), 2000, pp. 349-355
Authors:
Kosmas, C
Tsavaris, NB
Polyzos, A
Kalofonos, HP
Sepsas, E
Malamos, NA
Vadiaka, M
Dosios, T
Antonopoulos, MJ
Citation: C. Kosmas et al., A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma, CANCER, 89(4), 2000, pp. 774-782
Authors:
Kosmas, C
Tsavaris, NB
Polyzos, A
Malamos, NA
Katsikas, M
Antonopoulos, MJ
Citation: C. Kosmas et al., Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours, BR J CANC, 82(2), 2000, pp. 300-307
Authors:
Polyzos, A
Bramis, J
Delladetsima, JK
Sfikakis, PP
Citation: A. Polyzos et al., Prolonged survival in metastatic adenocarcinoma of the small intestine treated with irinotecan, CLIN DRUG I, 18(1), 1999, pp. 79-83
Authors:
Polyzos, A
Daskalopoulou, E
Giannitsiotis, E
Gatzonis, S
Sfikakis, PP
Citation: A. Polyzos et al., Transient encephalopathy followed by seizures after docetaxel infusion, CLIN DRUG I, 17(3), 1999, pp. 251-254
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Petrikos, G
Stamatiadis, D
Kalahanis, N
Giannopoulos, A
Karatzas, G
Sfikakis, PP
Citation: A. Polyzos et al., Double biochemical modulation of 5-fluorouracil by methotrexate and folinic acid for the treatment of advanced colorectal cancer, CLIN DRUG I, 17(2), 1999, pp. 83-88
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Petrikos, G
Giannikos, L
Kalahanis, N
Papadopoulos, O
Christodoulou, K
Giannakopoulos, K
Veslemes, M
Katsilambros, N
Citation: A. Polyzos et al., Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide, J CHEMOTHER, 11(2), 1999, pp. 144-149
Authors:
Polyzos, A
Tsavaris, N
Kosmas, C
Giannikos, L
Katsikas, M
Kalahanis, N
Karatzas, G
Christodoulou, K
Giannakopoulos, K
Stamatiadis, D
Katsilambros, N
Citation: A. Polyzos et al., A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer, ONCOL-BASEL, 56(4), 1999, pp. 291-296
Risultati:
1-10
|